Jynneos

Adult Dosing .

Dosage forms:  INJ

Special Note

[FDA emergency use authorization (EUA)]

Info: for active immunization by intradermal injection to prevent mpox disease in high-risk patients; available from Strategic National Stockpile, contact local health department

[mandatory reporting for EUA]

Info: vaccine administration errors, serious adverse events, myocarditis or pericarditis cases, and thromboembolic or neurovascular events following vaccination must be reported to Vaccine Adverse Event Reporting System (vaers.hhs.gov/reportevent.html or 1-800-822-7967) and Bavarian Nordic (1-844-4BAVARIAN)

smallpox disease prevention

[0.5 mL SC x2 doses 4wk apart]

Info: for high-risk patients, including immunocompromised patients

mpox disease prevention

[SC route]

Dose: 0.5 mL SC x2 doses 4wk apart; Info: for high-risk patients, including immunocompromised patients

[intradermal route]

Dose: 0.1 mL intradermally x2 doses 4wk apart; Info: for high-risk patients per FDA EUA

renal dosing

[not defined]

renal impairment: not defined

HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Dosage forms:  INJ

Special Note

[FDA emergency use authorization (EUA)]

Info: for active immunization by subcutaneous injection to prevent mpox disease in high-risk patients; available from Strategic National Stockpile, contact local health department

[mandatory reporting for EUA]

Info: vaccine administration errors, serious adverse events, myocarditis or pericarditis cases, and thromboembolic or neurovascular events following vaccination must be reported to Vaccine Adverse Event Reporting System (vaers.hhs.gov/reportevent.html or 1-800-822-7967) and Bavarian Nordic (1-844-4BAVARIAN)

mpox disease prevention

[0.5 mL SC x2 doses 4wk apart]

Info: for high-risk patients per FDA EUA

renal dosing

[not defined]

renal impairment: not defined

HD/PD: not defined

hepatic dosing

[not defined]